세계의 니코틴아미드 리보사이드(NR) 시장 : 분석 및 예측(2018-2029년)

Due to the COVID-19 pandemic and Russia-Ukraine War Influence, the global market for Nicotinamide Riboside (NR) was estimated at US$ 21.46 million in the year 2022, is projected to reach a revised size of US$ 38.76 million by 2029, growing at a CAGR of 8.32 % during the forecast period 2023-2029.

North American market for Nicotinamide Riboside (NR) was valued at $ 9.78 million in 2022 and will reach $ 17.90 million by 2029, at a CAGR of 8.49 % during the forecast period of 2023 through 2029.

Asia-Pacific market for Nicotinamide Riboside (NR) was valued at $ 6.55 million in 2022 and will reach $ 12.26 million by 2029, at a CAGR of 9.08 % during the forecast period of 2023 through 2029.

Europe market for Nicotinamide Riboside (NR) was valued at $ 3.59 million in 2022 and will reach $ 6.26 million by 2029, at a CAGR of 7.35 % during the forecast period of 2023 through 2029.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Nicotinamide Riboside (NR), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Nicotinamide Riboside (NR).

The Nicotinamide Riboside (NR) market size, estimations, and forecasts are provided in terms of sales volume (MT) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Nicotinamide Riboside (NR) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Nicotinamide Riboside (NR) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

Market Segmentation

This report covers the Nicotinamide Riboside (NR) segments by manufacturers, by Type, by Application, by region and country, and provides market size (value, volume and average price) and CAGR for the history and forecast period (2018-2022, 2023-2029), considering 2022 as the base year. It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.

By Company

• ChromaDex
• Genex Formulas
• Shandong Tianming Pharmaceutical
• Bontac
• Longer Livetech
• Tiantai Biotechnology
• EnzymeWorks
• Suzhou MyLand Pharm & Nutrition
• Shenzhen Ejion Biotechnology
• Zhejiang Jiahua
• Weitai Pharmaceutical

Segment by Type

• Purity ≤98%
• Purity >98%

Segment by Application

• Health Supplement
• Pharmaceutical Additives

By Region

• North America
  • U.S.
  • Canada

• Asia-Pacific
  • China
  • Japan
  • Korea
  • India
  • Thailand

• Europe
  • Germany
  • France
  • U.K.
  • Italy

• Latin America
  • Mexico
  • Brazil
  • Argentina

• Middle East & Africa
  • Middle East
  • Africa

Core Chapters

• Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, Latin America, Middle East & Africa.

• Chapter Two: Detailed analysis of Nicotinamide Riboside (NR) manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

• Chapter Three: Sales, revenue of Nicotinamide Riboside (NR) in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

• Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, Latin America, Middle East & Africa.

• Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, sales and revenue by country.

• Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

• Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

• Chapter Twelve: Analysis of sales channel, distributors and customers.

• Chapter Thirteen: Research Findings and Conclusion.

Table of Contents

1 Nicotinamide Riboside (NR) Market Overview

• 1.1 Nicotinamide Riboside (NR) Product Overview
• 1.2 Nicotinamide Riboside (NR) Market by Type
• 1.3 Global Nicotinamide Riboside (NR) Market Size by Type
  • 1.3.1 Global Nicotinamide Riboside (NR) Market Size Overview by Type (2018-2029)
  • 1.3.2 Global Nicotinamide Riboside (NR) Historic Market Size Review by Type (2018-2023)
  • 1.3.3 Global Nicotinamide Riboside (NR) Forecasted Market Size by Type (2024-2029)
• 1.4 Key Regions Market Size by Type
  • 1.4.1 North America Nicotinamide Riboside (NR) Sales Breakdown by Type (2018-2023)
  • 1.4.2 Europe Nicotinamide Riboside (NR) Sales Breakdown by Type (2018-2023)
  • 1.4.3 Asia-Pacific Nicotinamide Riboside (NR) Sales Breakdown by Type (2018-2023)
  • 1.4.4 Latin America Nicotinamide Riboside (NR) Sales Breakdown by Type (2018-2023)
  • 1.4.5 Middle East and Africa Nicotinamide Riboside (NR) Sales Breakdown by Type (2018-2023)

2 Nicotinamide Riboside (NR) Market Competition by Company

• 2.1 Global Top Players by Nicotinamide Riboside (NR) Sales (2018-2023)
• 2.2 Global Top Players by Nicotinamide Riboside (NR) Revenue (2018-2023)
• 2.3 Global Top Players by Nicotinamide Riboside (NR) Price (2018-2023)
• 2.4 Global Top Manufacturers Nicotinamide Riboside (NR) Manufacturing Base Distribution, Sales Area
• 2.5 Nicotinamide Riboside (NR) Market Competitive Situation and Trends
  • 2.5.1 Nicotinamide Riboside (NR) Market Concentration Rate (2018-2023)
  • 2.5.2 Global 3 and 6 Largest Manufacturers by Nicotinamide Riboside (NR) Sales and Revenue in 2022
• 2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Nicotinamide Riboside (NR) as of 2022)
• 2.7 Date of Key Manufacturers Established

3 Nicotinamide Riboside (NR) Status and Outlook by Region

• 3.1 Global Nicotinamide Riboside (NR) Market Size and CAGR by Region: 2018 VS 2022 VS 2029
• 3.2 Global Nicotinamide Riboside (NR) Historic Market Size by Region
  • 3.2.1 Global Nicotinamide Riboside (NR) Sales in Volume by Region (2018-2023)
  • 3.2.2 Global Nicotinamide Riboside (NR) Sales in Value by Region (2018-2023)
  • 3.2.3 Global Nicotinamide Riboside (NR) Sales (Volume & Value), Price and Gross Margin (2018-2023)
• 3.3 Global Nicotinamide Riboside (NR) Forecasted Market Size by Region
  • 3.3.1 Global Nicotinamide Riboside (NR) Sales in Volume by Region (2024-2029)
  • 3.3.2 Global Nicotinamide Riboside (NR) Sales in Value by Region (2024-2029)
  • 3.3.3 Global Nicotinamide Riboside (NR) Sales (Volume & Value), Price and Gross Margin (2024-2029)

4 Nicotinamide Riboside (NR) by Application

• 4.1 Nicotinamide Riboside (NR) Market by Application
  • 4.1.1 Health Supplement
  • 4.1.2 Pharmaceutical Additives
• 4.2 Global Nicotinamide Riboside (NR) Market Size by Application
  • 4.2.1 Global Nicotinamide Riboside (NR) Market Size Overview by Application (2018-2029)
  • 4.2.2 Global Nicotinamide Riboside (NR) Historic Market Size Review by Application (2018-2023)
  • 4.2.3 Global Nicotinamide Riboside (NR) Forecasted Market Size by Application (2024-2029)
• 4.3 Key Regions Market Size by Application
  • 4.3.1 North America Nicotinamide Riboside (NR) Sales Breakdown by Application (2018-2023)
  • 4.3.2 Europe Nicotinamide Riboside (NR) Sales Breakdown by Application (2018-2023)
  • 4.3.3 Asia-Pacific Nicotinamide Riboside (NR) Sales Breakdown by Application (2018-2023)
  • 4.3.4 Latin America Nicotinamide Riboside (NR) Sales Breakdown by Application (2018-2023)
  • 4.3.5 Middle East and Africa Nicotinamide Riboside (NR) Sales Breakdown by Application (2018-2023)

5 North America Nicotinamide Riboside (NR) by Country

• 5.1 North America Nicotinamide Riboside (NR) Historic Market Size by Country
  • 5.1.1 North America Nicotinamide Riboside (NR) Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
  • 5.1.2 North America Nicotinamide Riboside (NR) Sales in Volume by Country (2018-2023)
  • 5.1.3 North America Nicotinamide Riboside (NR) Sales in Value by Country (2018-2023)
• 5.2 North America Nicotinamide Riboside (NR) Forecasted Market Size by Country
  • 5.2.1 North America Nicotinamide Riboside (NR) Sales in Volume by Country (2024-2029)
  • 5.2.2 North America Nicotinamide Riboside (NR) Sales in Value by Country (2024-2029)

6 Europe Nicotinamide Riboside (NR) by Country

• 6.1 Europe Nicotinamide Riboside (NR) Historic Market Size by Country
  • 6.1.1 Europe Nicotinamide Riboside (NR) Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
  • 6.1.2 Europe Nicotinamide Riboside (NR) Sales in Volume by Country (2018-2023)
  • 6.1.3 Europe Nicotinamide Riboside (NR) Sales in Value by Country (2018-2023)
• 6.2 Europe Nicotinamide Riboside (NR) Forecasted Market Size by Country
  • 6.2.1 Europe Nicotinamide Riboside (NR) Sales in Volume by Country (2024-2029)
  • 6.2.2 Europe Nicotinamide Riboside (NR) Sales in Value by Country (2024-2029)

7 Asia-Pacific Nicotinamide Riboside (NR) by Region

• 7.1 Asia-Pacific Nicotinamide Riboside (NR) Historic Market Size by Region
  • 7.1.1 Asia-Pacific Nicotinamide Riboside (NR) Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
  • 7.1.2 Asia-Pacific Nicotinamide Riboside (NR) Sales in Volume by Region (2018-2023)
  • 7.1.3 Asia-Pacific Nicotinamide Riboside (NR) Sales in Value by Region (2018-2023)
• 7.2 Asia-Pacific Nicotinamide Riboside (NR) Forecasted Market Size by Region
  • 7.2.1 Asia-Pacific Nicotinamide Riboside (NR) Sales in Volume by Region (2024-2029)
  • 7.2.2 Asia-Pacific Nicotinamide Riboside (NR) Sales in Value by Region (2024-2029)

8 Latin America Nicotinamide Riboside (NR) by Country

• 8.1 Latin America Nicotinamide Riboside (NR) Historic Market Size by Country
  • 8.1.1 Latin America Nicotinamide Riboside (NR) Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
  • 8.1.2 Latin America Nicotinamide Riboside (NR) Sales in Volume by Country (2018-2023)
  • 8.1.3 Latin America Nicotinamide Riboside (NR) Sales in Value by Country (2018-2023)
• 8.2 Latin America Nicotinamide Riboside (NR) Forecasted Market Size by Country
  • 8.2.1 Latin America Nicotinamide Riboside (NR) Sales in Volume by Country (2024-2029)
  • 8.2.2 Latin America Nicotinamide Riboside (NR) Sales in Value by Country (2024-2029)

9 Middle East and Africa Nicotinamide Riboside (NR) by Country

• 9.1 Middle East and Africa Nicotinamide Riboside (NR) Historic Market Size by Country
  • 9.1.1 Middle East and Africa Nicotinamide Riboside (NR) Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
  • 9.1.2 Middle East and Africa Nicotinamide Riboside (NR) Sales in Volume by Country (2018-2023)
  • 9.1.3 Middle East and Africa Nicotinamide Riboside (NR) Sales in Value by Country (2018-2023)
• 9.2 Middle East and Africa Nicotinamide Riboside (NR) Forecasted Market Size by Country
  • 9.2.1 Middle East and Africa Nicotinamide Riboside (NR) Sales in Volume by Country (2024-2029)
  • 9.2.2 Middle East and Africa Nicotinamide Riboside (NR) Sales in Value by Country (2024-2029)

10 Company Profiles

• 10.1 ChromaDex
  • 10.1.1 ChromaDex Company Information
  • 10.1.2 ChromaDex Introduction and Business Overview
  • 10.1.3 ChromaDex Nicotinamide Riboside (NR) Sales, Revenue and Gross Margin (2018-2023)
  • 10.1.4 ChromaDex Nicotinamide Riboside (NR) Products Offered
  • 10.1.5 ChromaDex Recent Development
• 10.2 Genex Formulas
  • 10.2.1 Genex Formulas Company Information
  • 10.2.2 Genex Formulas Introduction and Business Overview
  • 10.2.3 Genex Formulas Nicotinamide Riboside (NR) Sales, Revenue and Gross Margin (2018-2023)
  • 10.2.4 Genex Formulas Nicotinamide Riboside (NR) Products Offered
• 10.3 Shandong Tianming Pharmaceutical
  • 10.3.1 Shandong Tianming Pharmaceutical Company Information
  • 10.3.2 Shandong Tianming Pharmaceutical Introduction and Business Overview
  • 10.3.3 Shandong Tianming Pharmaceutical Nicotinamide Riboside (NR) Sales, Revenue and Gross Margin (2018-2023)
  • 10.3.4 Shandong Tianming Pharmaceutical Nicotinamide Riboside (NR) Products Offered
• 10.4 Bontac
  • 10.4.1 Bontac Company Information
  • 10.4.2 Bontac Introduction and Business Overview
  • 10.4.3 Bontac Nicotinamide Riboside (NR) Sales, Revenue and Gross Margin (2018-2023)
  • 10.4.4 Bontac Nicotinamide Riboside (NR) Products Offered
• 10.5 Longer Livetech
  • 10.5.1 Longer Livetech Company Information
  • 10.5.2 Longer Livetech Introduction and Business Overview
  • 10.5.3 Longer Livetech Nicotinamide Riboside (NR) Sales, Revenue and Gross Margin (2018-2023)
  • 10.5.4 Longer Livetech Nicotinamide Riboside (NR) Products Offered
• 10.6 Tiantai Biotechnology
  • 10.6.1 Tiantai Biotechnology Company Information
  • 10.6.2 Tiantai Biotechnology Introduction and Business Overview
  • 10.6.3 Tiantai Biotechnology Nicotinamide Riboside (NR) Sales, Revenue and Gross Margin (2018-2023)
  • 10.6.4 Tiantai Biotechnology Nicotinamide Riboside (NR) Products Offered
• 10.7 EnzymeWorks
  • 10.7.1 EnzymeWorks Company Information
  • 10.7.2 EnzymeWorks Introduction and Business Overview
  • 10.7.3 EnzymeWorks Nicotinamide Riboside (NR) Sales, Revenue and Gross Margin (2018-2023)
  • 10.7.4 EnzymeWorks Nicotinamide Riboside (NR) Products Offered
• 10.8 Suzhou MyLand Pharm & Nutrition
  • 10.8.1 Suzhou MyLand Pharm & Nutrition Company Information
  • 10.8.2 Suzhou MyLand Pharm & Nutrition Introduction and Business Overview
  • 10.8.3 Suzhou MyLand Pharm & Nutrition Nicotinamide Riboside (NR) Sales, Revenue and Gross Margin (2018-2023)
  • 10.8.4 Suzhou MyLand Pharm & Nutrition Nicotinamide Riboside (NR) Products Offered
• 10.9 Shenzhen Ejion Biotechnology
  • 10.9.1 Shenzhen Ejion Biotechnology Company Information
  • 10.9.2 Shenzhen Ejion Biotechnology Introduction and Business Overview
  • 10.9.3 Shenzhen Ejion Biotechnology Nicotinamide Riboside (NR) Sales, Revenue and Gross Margin (2018-2023)
  • 10.9.4 Shenzhen Ejion Biotechnology Nicotinamide Riboside (NR) Products Offered
• 10.10 Zhejiang Jiahua
  • 10.10.1 Zhejiang Jiahua Company Information
  • 10.10.2 Zhejiang Jiahua Introduction and Business Overview
  • 10.10.3 Zhejiang Jiahua Nicotinamide Riboside (NR) Sales, Revenue and Gross Margin (2018-2023)
  • 10.10.4 Zhejiang Jiahua Nicotinamide Riboside (NR) Products Offered
• 10.11 Weitai Pharmaceutical
  • 10.11.1 Weitai Pharmaceutical Company Information
  • 10.11.2 Weitai Pharmaceutical Introduction and Business Overview
  • 10.11.3 Weitai Pharmaceutical Nicotinamide Riboside (NR) Sales, Revenue and Gross Margin (2018-2023)
  • 10.11.4 Weitai Pharmaceutical Nicotinamide Riboside (NR) Products Offered

11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis

• 11.1 Nicotinamide Riboside (NR) Key Raw Materials
  • 11.1.1 Key Raw Materials
  • 11.1.2 Key Raw Materials Price
  • 11.1.3 Raw Materials Key Suppliers
• 11.2 Manufacturing Cost Structure
  • 11.2.1 Raw Materials
  • 11.2.2 Labor Cost
  • 11.2.3 Manufacturing Expenses
• 11.3 Nicotinamide Riboside (NR) Industrial Chain Analysis
• 11.4 Nicotinamide Riboside (NR) Market Dynamics
  • 11.4.1 Nicotinamide Riboside (NR) Industry Trends
  • 11.4.2 Nicotinamide Riboside (NR) Market Drivers
  • 11.4.3 Nicotinamide Riboside (NR) Market Challenges
  • 11.4.4 Nicotinamide Riboside (NR) Market Restraints

12 Marketing Strategy Analysis, Distributors

• 12.1 Sales Channel
• 12.2 Nicotinamide Riboside (NR) Distributors
• 12.3 Nicotinamide Riboside (NR) Downstream Customers

13 Research Findings and Conclusion

14 Appendix

• 14.1 Research Methodology
  • 14.1.1 Methodology/Research Approach
  • 14.1.2 Data Source
• 14.2 Author Details
• 14.3 Disclaimer